Preliminary scientific tests suggest conolidine could inhibit specific ion channels, decreasing neuronal excitability and restricting suffering alerts. This system is particularly applicable in neuropathic pain, in which irregular signaling causes persistent irritation. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to soreness perception. ... https://everettq738ldu4.wikilowdown.com/user